Mixed teratoma and seminoma

Summary

Mixed teratoma and seminoma (MONDO:0024861) is a disease. A subtype of mixed germ cell tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	mixed teratoma and seminoma
Mondo ID	MONDO:0024861
NCIT	C9010
UMLS	C5848073
MedGen	1844722
GARD	0025466
Is cancer (heuristic)	no

Also known as: mixed teratoma and seminoma

Disease family

This is a subtype of mixed germ cell tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › malignant germ cell tumor › mixed germ cell tumor › mixed teratoma and seminoma

Related subtypes (5): mixed extragonadal germ cell cancer, teratocarcinoma, mixed testicular germ cell cancer, ovarian mixed germ cell neoplasm, mixed germ cell tumor of vulva

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.